Buying Options
| Kindle Price: | £0.00 |
You’ve got a Kindle.
Download the free Kindle app and start reading Kindle books instantly on your smartphone, tablet or computer - no Kindle device required. Learn more.
Read instantly on your browser with Kindle Cloud Reader.
Using your mobile phone camera - scan the code below and download the Kindle app.
Enter your mobile phone or email address
By pressing ‘Send link’, you agree to Amazon's Conditions of Use.
You consent to receive an automated text message from or on behalf of Amazon about the Kindle App at your mobile number above. Consent is not a condition of any purchase. Message and data rates may apply.
Follow the author
OK
The Tumor: A Non-Legal Thriller Kindle Edition
| John Grisham (Author) See search results for this author |
| Amazon Price | New from | Used from |
Explore your book, then jump right back to where you left off with Page Flip.
View high quality images that let you zoom in to take a closer look.
Enjoy features only possible in digital – start reading right away, carry your library with you, adjust the font, create shareable notes and highlights, and more.
Discover additional details about the events, people, and places in your book, with Wikipedia integration.
THE TUMOR follows the present day experience of the fictional patient Paul, an otherwise healthy 35-year-old father who is diagnosed with a malignant brain tumor. Grisham takes readers through a detailed account of Paul’s treatment and his family’s experience that doesn’t end as we would hope. Grisham then explores an alternate future, where Paul is diagnosed with the same brain tumor at the same age, but in the year 2025, when a treatment called focused ultrasound is able to extend his life expectancy.
Focused ultrasound has the potential to treat not just brain tumors, but many other disorders, including Parkinson’s, Alzheimer’s, hypertension, and prostate, breast and pancreatic cancer.
For more information, you can visit The Focused Ultrasound Foundation’s website. Here you will find a video of Grisham on the TEDx stage with the Foundation’s chairman and a Parkinson’s patient who brings the audience to its feet sharing her incredible story of a focused ultrasound “miracle.”
Readers will get a taste of the narrative they expect from Grisham, but this short book will also educate and inspire people to be hopeful about the future of medical innovation.
- LanguageEnglish
- Publication date19 Jan. 2016
- File size21664 KB
Product details
- ASIN : B01AUYDNI6
- Publisher : Focused Ultrasound Foundation; 3rd edition (19 Jan. 2016)
- Language : English
- File size : 21664 KB
- Simultaneous device usage : Unlimited
- Text-to-Speech : Enabled
- Screen Reader : Supported
- Enhanced typesetting : Enabled
- X-Ray : Enabled
- Word Wise : Enabled
- Print length : 70 pages
- Best Sellers Rank: #1,586 Free in Kindle Store (See Top 100 in Kindle Store)
- Customer reviews:
About the author

Long before his name became synonymous with the modern legal thriller, he was working 60-70 hours a week at a small Southaven, Mississippi, law practice, squeezing in time before going to the office and during courtroom recesses to work on his hobby—writing his first novel.
Born on February 8, 1955 in Jonesboro, Arkansas, to a construction worker and a homemaker, John Grisham as a child dreamed of being a professional baseball player. Realizing he didn’t have the right stuff for a pro career, he shifted gears and majored in accounting at Mississippi State University. After graduating from law school at Ole Miss in 1981, he went on to practice law for nearly a decade in Southaven, specializing in criminal defense and personal injury litigation. In 1983, he was elected to the state House of Representatives and served until 1990.
One day at the DeSoto County courthouse, Grisham overheard the harrowing testimony of a twelve-year-old rape victim and was inspired to start a novel exploring what would have happened if the girl’s father had murdered her assailants. Getting up at 5 a.m. every day to get in several hours of writing time before heading off to work, Grisham spent three years on A Time to Kill and finished it in 1987. Initially rejected by many publishers, it was eventually bought by Wynwood Press, who gave it a modest 5,000 copy printing and published it in June 1988.
That might have put an end to Grisham’s hobby. However, he had already begun his next book, and it would quickly turn that hobby into a new full-time career—and spark one of publishing’s greatest success stories. The day after Grisham completed A Time to Kill, he began work on another novel, the story of a hotshot young attorney lured to an apparently perfect law firm that was not what it appeared. When he sold the film rights to The Firm to Paramount Pictures for $600,000, Grisham suddenly became a hot property among publishers, and book rights were bought by Doubleday. Spending 47 weeks on The New York Times bestseller list, The Firm became the bestselling novel of 1991.
The successes of The Pelican Brief, which hit number one on the New York Times bestseller list, and The Client, which debuted at number one, confirmed Grisham’s reputation as the master of the legal thriller. Grisham’s success even renewed interest in A Time to Kill, which was republished in hardcover by Doubleday and then in paperback by Dell. This time around, it was a bestseller.
Since first publishing A Time to Kill in 1988, Grisham has written at least one book a year (his other works are The Firm, The Pelican Brief, The Client, The Chamber, The Rainmaker, The Runaway Jury, The Partner, The Street Lawyer, The Testament, The Brethren, A Painted House, Skipping Christmas, The Summons, The King of Torts, Bleachers, The Last Juror, The Broker, Playing for Pizza, The Appeal, The Associate, The Confession, The Litigators, Calico Joe, The Racketeer, Sycamore Row, Gray Mountain, Rogue Lawyer, The Whistler, Camino Island, The Rooster Bar, The Reckoning, and The Guardians) and all of them have become international bestsellers. There are currently more than 350 million John Grisham books in print worldwide, which have been translated into 45 languages. Nine of his novels have been turned into films (The Firm, The Pelican Brief, The Client, A Time to Kill, The Rainmaker, The Chamber, A Painted House, The Runaway Jury, and Skipping Christmas), as was an original screenplay, The Gingerbread Man. The Innocent Man (October 2006) marked his first foray into non-fiction, and Ford County (November 2009) was his first short story collection. In addition, Grisham has written seven novels for young adults, all in the Theodore Boone series: Kid Lawyer, The Abduction, The Accused, The Activist, The Fugitive, The Scandal, and The Accomplice.
Grisham took time off from writing for several months in 1996 to return, after a five-year hiatus, to the courtroom. He was honoring a commitment made before he had retired from the law to become a full-time writer: representing the family of a railroad brakeman killed when he was pinned between two cars. Preparing his case with the same passion and dedication as his books’ protagonists, Grisham successfully argued his clients’ case, earning them a jury award of $683,500—the biggest verdict of his career.
When he’s not writing, Grisham devotes time to charitable causes, including most recently his Rebuild The Coast Fund, which raised 8.8 million dollars for Gulf Coast relief in the wake of Hurricane Katrina. He also keeps up with his greatest passion: baseball. The man who dreamed of being a professional baseball player now serves as the local Little League commissioner. The six ballfields he built on his property have played host to over 350 kids on 26 Little League teams.
More items to explore
Customer reviews
Top reviews from United Kingdom
There was a problem filtering reviews right now. Please try again later.
In hospital Paul a fictious character aged 35 is diagnosed with a malignant brain tumor which is removed and the tumor is back and Paul endures another operation to remove it again. Paul's story is heartbreaking.
John shows the reader another scenario which brings the latest medical technology into being called focused ultra sound and how Paul goes through this treatment to eradicate his tumor without having to go through the invasive surgery he had ten years earlier and can extends one's life expectancy.
Focused ultrasound has the potential to treat not just brain tumors, but many other disorders, including Parkinson’s, Alzheimer’s, hypertension, and prostate, breast and pancreatic cancer.
So too, Grisham has written one non-fiction book, "The Innocent Man". This was an exploration of "small town justice gone terribly awry". This is the story of a one-time major league baseball player who was wrongly convicted of rape. The cover notes of this book state that "If you believe that in America you are innocent until proven guilty, this book will shock you. If you believe in the death penalty, this book will disturb you."
Now John Grisham enhances his vision and widens his literary appeal with a couple of short novels (novellas) from a different literary genre.
The first of these is called "The Tumor" (note the American spelling). This is the apparently true account of a family man, Paul, who was born in 1980. At age thirty five, Paul is diagnosed with, and undergoes treatment for, a brain tumor with the medical title of a “glioblastoma”. It is one of the rarest and deadliest of brain cancers. Grisham informs the reader that some of the well-known persons who have died from this illness include Wilma Rudolph (athlete), George Gershwin (composer), “Ted” Kennedy (politician), Susan Hayward (actress) and “Beau” Biden (youngest son of the current presidential candidate, Joe Biden).
The writer tells the story of Paul’s brain cancer and how it ended his life - with effects on family, friends, and work colleagues.
Grisham then retells the story as if Paul had been born ten years latter and how this would have resulted in new forms of treatment, particularly a treatment known as “Focused Ultrasound”, and greater life expectancy. It is an effective method of storytelling, inviting access to the deeper details of the story and an appreciation of the medical involvement and apparatus - present and future. The text is accompanied with appropriate pictures, statistics, and diagrams.
Grisham’s short story serves more than the simple purpose of telling another story. He has an obvious personal interest in the new form of “Focused Ultrasound” treatment for brain cancer, as well as its suitability for treating other forms of cancer. Grisham says that “I have found no other cause, issue, non-profit, or charity that can potentially save so many lives. One day in the not-too-distant future, you, or someone you love, will be diagnosed with a tumor. After the shock, you will think of focused ultrasound. Let us hope it’s available”. It is for this reason that John Grisham considers that this story is the most important which he has written and been published. This self-opinion deserves due consideration, if not agreement.
It would seem, therefore, that John Grisham has written this story to promote, in his own inimitable way, the work of the “Focused Ultrasound Foundation”. This endeavour attracts admiration for the author in publishing Paul’s story and making “Focused Ultrasound” more widely known. There is no suggestion that he will personally benefit from effectively advertising this treatment and the foundation that champions it. He seems to have used his literary gifts for the benefit of others. Still, there may be those who believe that his motives are otherwise. In the matter of John Grisham, however, reader cynicism is not well-founded. Being a member of the board of the “Focused Ultrasound Foundation” does not de-legitimise Grisham's pursuit of making the public aware of its existence - on the contrary.
This short story is an undemanding physical read, but it may have an emotional appeal to some readers. It is a worthwhile read and is recommended for its practical ramifications, as well as being satisfactory literature. The short story is currently available only in its Kindle edition - from which this review was undertaken.
John Grisham has used his name to further a technology relatively unknown to most healthy (sometimes even the unwell) population; he is "peddling" this to bring it to the attention of his wide readers base.
Please let's not undermine every single thing just because internet has allowed us to become "reviewers". I agree with the reviewers who are reviewing solely the writing and not the content. However, those who are trying to criticise the content as not being the usual Grisham material, I genuinely humbly suggest reading a little about the book before you pick it up. A simple Google search would prepare you quickly for what the book is about to deliver.





